For the Inventor, By the Inventor

Enter assignee name

Burlington, MA, United States of America

Dyax Corporation

USPTO Granted Patents = 174

% Expired Patents = 17.2

CIPO Patents = 14

EPO Patents = 49

Forward Citations = 2,827

Loading Chart...

Loading Chart...

136 inventors (with patents filed for the assignee):

Robert Charles Ladner (85 out of 107 patents)

Arthur Charles Ley (24 out of 30 patents)

Daniel T Dransfield (23 out of 24 patents)

4. Daniel J Sexton (20 out of 43 patents)

5. Aaron Sato (20 out of 80 patents)

6. William Markland (20 out of 27 patents)

7. Simon E Hufton (14 out of 14 patents)

8. Rene Hoet (13 out of 23 patents)

9. Peter C Van Davelaar (13 out of 22 patents)

10. Anthony Williams (12 out of 13 patents)

11. Malini Viswanathan (11 out of 20 patents)

12. Hendricus Renerus Jacobus Mattheus Hoogenboom (11 out of 28 patents)

13. Palaniappa Nanjappan (11 out of 34 patents)

14. Clive R Wood (11 out of 37 patents)

15. Shirish Hirani (10 out of 11 patents)

Core Competencies:

Kallikrein Inhibitors

Monoclonal Antibodies

Genetic Libraries

Fc Receptor Antibodies

Peptide Binding

Plasma Protease

Multi-Chain Vectors

Ligand Screening

Ophthalmic Disorders

Autoimmune Diseases

Therapeutic Constructs

Blood Loss Prevention

174 patents: Sort by Forward Citations

1. 12528880 - PLASMA KALLIKREIN INHIBITORS AND USES THEREOF FOR TREATING PEDIATRIC HEREDITARY ANGIOEDEMA ATTACK (2026-01-20),

2. 11014988 - Nucleic acids encoding anti-neonatal Fc receptor (FcRn) antibodies (2021-05-25),

3. 10914747 - Immunoassay to detect cleaved high molecular weight kininogen (2021-02-09),

4. 10913802 - Monoclonal antibody inhibitor of factor XIIA (2021-02-09),

5. 10870115 - Evacuated blood collection tubes containing protease inhibitors for the assessment of contact system activation (2020-12-22),

6. 10829541 - Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries (2020-11-10),

7. 10718066 - Libraries of genetic packages comprising novel HC CDR3 designs (2020-07-21),

8. 10690670 - Assays for determining levels of plasma protease C1 inhibitor (2020-06-23),

9. 10683342 - Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designs (2020-06-16),

10. 10648990 - Diagnosis and treatment of autoimmune diseases (2020-05-12),

11. 10604753 - Focused libraries of genetic packages (2020-03-31),

12. 10577599 - Multi-chain eukaryotic display vectors and uses thereof (2020-03-03),

13. 10577598 - Display library process (2020-03-03),

14. 10479834 - Fc receptor antibodies and methods of use thereof (2019-11-19),

15. 10428158 - Compositions and methods for treatment of diabetic macular edema (2019-10-01),

Company Overview

Dyax Corporation, based in Burlington, MA, specializes in the development of innovative therapeutic solutions, particularly focusing on kallikrein inhibitors. The company leverages advanced technologies such as monoclonal antibodies and genetic libraries to create targeted treatments. Their expertise extends to peptide binding, plasma protease modulation, and the use of multi-chain vectors for ligand screening. Dyax is committed to addressing unmet medical needs through cutting-edge research in biopharmaceuticals.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

174 Patents

#4 in Burlington, MA

#126 in Massachusetts

#2,308 in US

#4,767 in the World

Burlington, MA, United States of America

Dyax Corporation

Forward Citations = 2,827

136 inventors:

Robert Charles Ladner (85 out of 107 patents)

Arthur Charles Ley (24 out of 30 patents)

Daniel T Dransfield (23 out of 24 patents)

4. Daniel J Sexton (20 out of 43 patents)

5. Aaron Sato (20 out of 80 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dyax Corporation. Retrieved from https://idiyas.com/company/dyax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…